04/18/2024
3:49 PM | ALX Oncology (Issuer)
Pons Jaume (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:34 PM | ALX Oncology (Subject)
Pons Jaume (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
4:37 PM | ALX Oncology (Issuer)
Pons Jaume (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:37 PM | ALX Oncology (Subject)
Pons Jaume (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
5:24 PM | ALX Oncology (Issuer)
Pinto Shelly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
5:03 PM | ALX Oncology (Issuer)
Lettmann Jason (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
5:09 PM | ALX Oncology (Issuer)
Pons Jaume (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/16/2024
5:17 PM | ALX Oncology (Issuer)
Randolph Sophia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
5:21 PM | ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:45 PM | ALX Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
6:28 PM | ALX Oncology (Subject)
LSV Associates, LLC (Filed by)
| Form SC 13D/A | |
02/09/2024
7:35 AM | ALX Oncology (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
10/16/2023
4:15 PM | ALX Oncology (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G | |
10/13/2023
3:00 PM | ALX Oncology (Subject)
Cormorant Asset Management, LP (Filed by)
| Form SC 13G | |
10/06/2023
5:05 AM | ALX Oncology (Filer)
| Form 424B5 | |
10/06/2023
5:06 AM | ALX Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
4:21 PM | ALX Oncology (Filer)
| Form 424B5 | |
10/04/2023
4:21 PM | ALX Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
7:00 AM | ALX Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
3:24 PM | ALX Oncology (Issuer)
Lettmann Jason (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2023
11:15 PM | ALX Oncology (Filer)
| Form EFFECT | |
09/08/2023
3:25 PM | ALX Oncology (Filer)
| Form 424B3 | |
09/01/2023
3:11 PM | ALX Oncology (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/25/2023
3:44 PM | ALX Oncology (Filer)
| Form 424B5 | |
07/07/2023
3:09 PM | ALX Oncology (Issuer)
Pinto Shelly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:51 PM | ALX Oncology (Issuer)
Nielsen Jack (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:43 PM | ALX Oncology (Issuer)
Hemrajani Rekha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:46 PM | ALX Oncology (Issuer)
Lettmann Jason (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:30 PM | ALX Oncology (Issuer)
Garland J. Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:32 PM | ALX Oncology (Issuer)
GOODMAN COREY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:27 PM | ALX Oncology (Issuer)
Canamasas Itziar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
7:45 AM | ALX Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
3:38 PM | ALX Oncology (Issuer)
Randolph Sophia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
